Pure Bioscience, Inc. (PURE) stock
PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
$0.07−0.01 (-12.10%)
Close on Oct 19, 2026Market cap $8.67MP/E –Yield –
Pure Bioscience profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Pure Bioscience's profit margin for the twelve months ending Jul 31, 2026 was -107.3%. For fiscal 2026 it was -107.3%, against -109.1% the year before. The highest annual figure on record is 0.1% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | -107.3% | +1.9 |
| FY2025 | Jul 31, 2025 | -109.1% | +62.2 |
| FY2024 | Jul 31, 2024 | -171.4% | +40.3 |
| FY2023 | Jul 31, 2023 | -211.7% | −19.2 |
| FY2022 | Jul 31, 2022 | -192.6% | −129.8 |
| FY2021 | Jul 31, 2021 | -62.7% | −62.8 |
| FY2020 | Jul 31, 2020 | 0.1% | +343.4 |
| FY2019 | Jul 31, 2019 | -343.3% | +76.2 |
| FY2018 | Jul 31, 2018 | -419.5% | −77.5 |
| FY2017 | Jul 31, 2017 | -342.1% | +772.8 |
| FY2016 | Jul 31, 2016 | -1114.9% | −68.7 |
| FY2015 | Jul 31, 2015 | -1046.2% | +962.9 |
| FY2014 | Jul 31, 2014 | -2009.1% | −1073.6 |
| FY2013 | Jul 31, 2013 | -935.5% | +159.3 |
| FY2012 | Jul 31, 2012 | -1094.8% | +704.5 |
| FY2011 | Jul 31, 2011 | -1799.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | -92.6% | −49.1 |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | -123.3% | −4.7 |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | -177.2% | +26.9 |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | -65.6% | +58.5 |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | -43.5% | +116.7 |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | -118.6% | +76.2 |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | -204.1% | +104.2 |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | -124.1% | −21.8 |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | -160.2% | +11.3 |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | -194.8% | +21.0 |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | -308.3% | −40.6 |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | -102.4% | +110.3 |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | -171.4% | +133.8 |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | -215.8% | −62.8 |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | -267.7% | −98.5 |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | -212.6% | −52.5 |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | -305.2% | −219.7 |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | -152.9% | −7.1 |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | -169.2% | −100.6 |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | -160.2% | −147.5 |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | -85.5% | −119.0 |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | -145.9% | −167.2 |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | -68.5% | +122.3 |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | -12.7% | +270.0 |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | 33.5% | +167.1 |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | 21.3% | +621.6 |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | -190.8% | +138.1 |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | -282.7% | +152.3 |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | -133.6% | +138.3 |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | -600.3% | −166.5 |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | -328.9% | +164.3 |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | -434.9% | +69.2 |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | -271.9% | +86.5 |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | -433.8% | +80.4 |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | -493.2% | −283.8 |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | -504.1% | −175.8 |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | -358.4% | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | -514.2% | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | -209.4% | – |
| Q1 FY2017CQ3 2016 | Oct 31, 2016 | -328.2% | – |
See a number that looks wrong?